RxDoctor Payments DataLook up a doctor →

Michael Cannon, MD

Hematology & Oncology · Pittsburgh, KSNPI 1982666236

Payments from drug & device makers

$9,353in general payments, 2019–2025

Across 331 payments — averaging $28.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dova Pharmaceuticals$993
  • AbbVie$955
  • Rigel Pharmaceuticals, Inc.$877
  • AstraZeneca$686
  • Novartis$608
  • Pfizer$581
  • plus $5K from 43 others

What the payments were for

  • Consulting fees$1,77519%
  • Speaking & faculty fees$8509%
  • Food & beverage$6,47269%
  • Education$2563%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,353 in reported general payments places this provider in the 55th percentile of 97 hematology & oncology providers in Kansas.

See all hematology & oncology providers in Kansas

Medicare billing

Part B allowed, 2024
$24,444
Medicare patients
118
Services billed
460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lenalidomide13$229,391
Dexamethasone21$556
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen22$468
Morphine Sulfate ErMorphine Sulfate16$403
Letrozole27$263
Hydroxyurea12$210
Venlafaxine Hcl ErVenlafaxine Hcl41$164
Prednisone19$88
Ondansetron Hcl14$85
Anastrozole17$76

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Pittsburgh

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →